Pharma exec up for Patient Choice gong

Seventy-seven finalists - including one pharma executive - have been named across 15 categories for the 2026 Patient’s Choice Awards, each nominated by the patients, families, colleagues and communities who have experienced their work first-hand.

The awards recognise individuals and organisations for their work in building a more patient-centred, equitable and responsive health system, with patient and carer advocates, frontline clinicians, hospitals and clinics, community pharmacists, digital health providers, researchers and not-for-profit organisations among those named finalists.

“You cannot underestimate what it means to people who care deeply, and who deliver care, research or innovation exceptionally well, to feel seen. The joy people share with us when they learn they have been nominated, or that they are a finalist, is genuinely affirming,” Patients Australia CEO, Lisa Robins, said.